A detailed history of Altium Wealth Management LLC transactions in Talaris Therapeutics, Inc. stock. As of the latest transaction made, Altium Wealth Management LLC holds 59,520 shares of TALS stock, worth $161,894. This represents 0.02% of its overall portfolio holdings.

Number of Shares
59,520
Previous 59,520 -0.0%
Holding current value
$161,894
Previous $586,000 54.27%
% of portfolio
0.02%
Previous 0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

BUY
$12.18 - $17.0 $724,953 - $1.01 Million
59,520 New
59,520 $910,000

Others Institutions Holding TALS

About Talaris Therapeutics, Inc.


  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Altium Wealth Management LLC Portfolio

Follow Altium Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altium Wealth Management LLC with notifications on news.